Nefroloxía
Servizo
![Foto de Nefroloxía](/img/noimage.png)
![Foto de University of Groningen](/img/noimage_org.png)
University of Groningen
Groninga, HolandaPublicacións en colaboración con investigadores/as de University of Groningen (21)
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
-
Association of obesity with 3-month mortality in kidney failure patients with COVID-19
Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1348-1360
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19
Transplantation, Vol. 106, Núm. 5, pp. 1012-1023
-
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 5, pp. 994-999
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
2021
-
COVID-19-related mortality in kidney transplant and haemodialysis patients: A comparative, prospective registry-based study
Nephrology Dialysis Transplantation, Vol. 36, Núm. 11, pp. 2094-2105
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
2020
-
COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983
-
Complement genes contribute sex-biased vulnerability in diverse disorders
Nature, Vol. 582, Núm. 7813, pp. 577-581
-
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia
Nature Neuroscience, Vol. 23, Núm. 2, pp. 179-184
2019
-
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk
Nature Genetics, Vol. 51, Núm. 4, pp. 659-674
-
Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4)
Nature Genetics
2018
-
Age at first birth in women is genetically associated with increased risk of schizophrenia
Scientific Reports, Vol. 8, Núm. 1
2017
-
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
Nature Genetics, Vol. 49, Núm. 1, pp. 27-35
-
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
Nature Communications, Vol. 8
2016
-
Genetic influences on schizophrenia and subcortical brain volumes: Large-scale proof of concept
Nature Neuroscience, Vol. 19, Núm. 3, pp. 420-431
2015
-
LD score regression distinguishes confounding from polygenicity in genome-wide association studies
Nature Genetics, Vol. 47, Núm. 3, pp. 291-295
2014
-
Biological insights from 108 schizophrenia-associated genetic loci
Nature, Vol. 511, Núm. 7510, pp. 421-427